NRC Health Common Stock (NRC)
Stock · NASDAQ · Health Care
$20.14as of 10/16/2026
Price chart
Active signals
NRC Signal Track Record
How signals performed across all stocks →What NRC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 31 | -2.4% | 42% | September 18, 2026 |
| Bollinger Band Breakdown | 24 | -2.0% | 46% | September 25, 2026 |
| Bollinger Band Breakout | 19 | +5.9% | 68% | June 29, 2026 |
| 200-Day Moving Average TouchActive now | 15 | +2.0% | 60% | February 4, 2026 |
| Any 20-session window (baseline) | -0.6% | 47% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About NRC
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of commun…
- Sector
- Health Care
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Employees
- 357
- Website
- nrchealth.com/
Fundamentals
- 1-day range
- $20.61$21.5
- Market cap
- $430.67M
- P/E (trailing)
- 79.70
- P/E (forward)
- 20.10
- EPS (trailing)
- $0.27
- Dividend yield
- 1.16%
- Beta
- 0.26
- Avg. volume
- 115.7K
- Ex-dividend date
- September 25, 2026
- Dividend pay date
- October 9, 2026
How NRC Health Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 5, 2026 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
NRC Health Common Stock Competitors
Chosen by industry and closest market cap.
- NRCNRC Health Common Stock$20.15▼ 4.55%Market cap $430.67MP/E 79.70$11.01$23.68
- OABIOmniAb Inc. Common Stock$4.59▼ 2.96%Market cap $324.74MP/E —$1.3$5.43
- MXCTMaxCyte Inc. Common Stock$1.3▲ 0.00%Market cap $118.91MP/E —$0.643$1.87
- ONMDOneMedNet Corp Class A Common Stock$4.51▼ 5.05%Market cap $37.18MP/E —$4.9$42.2
- BIAFbioAffinity Technologies Inc. Common Stock$3.73▼ 5.81%Market cap $4.12MP/E —$4.56$80.7
- ISPCiSpecimen Inc. Common Stock$0.917▼ 10.97%Market cap $3.35MP/E —$1.02$36.32
- ABSIAbsci Corporation Common Stock$8.25▼ 7.09%Market cap $1.29BP/E —$2.24$12.06
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NRC NRC Health Common Stock | $430.67M | 79.70 | $20.15 | ▼ 4.55% | $11.01$23.68 |
| OABI OmniAb Inc. Common Stock | $324.74M | — | $4.59 | ▼ 2.96% | $1.3$5.43 |
| MXCT MaxCyte Inc. Common Stock | $118.91M | — | $1.3 | ▲ 0.00% | $0.643$1.87 |
| ONMD OneMedNet Corp Class A Common Stock | $37.18M | — | $4.51 | ▼ 5.05% | $4.9$42.2 |
| BIAF bioAffinity Technologies Inc. Common Stock | $4.12M | — | $3.73 | ▼ 5.81% | $4.56$80.7 |
| ISPC iSpecimen Inc. Common Stock | $3.35M | — | $0.917 | ▼ 10.97% | $1.02$36.32 |
| ABSI Absci Corporation Common Stock | $1.29B | — | $8.25 | ▼ 7.09% | $2.24$12.06 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →- Bhandari Parul · June 23, 2026 · Grant7.7K
- Wheeler Penny Ann · June 23, 2026 · Grant7.7K
- Stephen H. Lockhart · June 23, 2026 · Grant7.7K
- Berwick Donald M · June 23, 2026 · Grant7.7K
- NUNNELLY JOHN N · June 23, 2026 · Grant7.7K
Institutional Ownership
March 31, 2026
- Total shares held
- 10.73M
- Total value held
- $171.78M
- Institutional holders
- 117
- Unknown2.64M
- Unknown1.00M
- Unknown975.9K
- Unknown662.8K
- Unknown489.7K
- Unknown393.8K
- Unknown381.3K
- Unknown340.8K
- Unknown300.7K
- Unknown286.8K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
NRC Health dividend and governance topics in focus
Recent coverage highlights NRC Health's dividend profile and broader discussions on hospital board governance. The stock is currently trading with a low RSI and near a key support level, reflecting cautious sentiment. These articles provide context on the company's financial policies and industry standards rather than reporting on a specific corporate event.
NRC Health dividend and governance topics in focus. Recent coverage highlights NRC Health's dividend profile and broader discussions on hospital board governance. The stock is currently trading with a low RSI and near a key support level, reflecting cautious sentiment. These articles provide context on the company's financial policies and industry standards rather than reporting on a specific corporate event.